Prandin and Appendicitis - a phase IV clinical study of FDA data

Summary:

Appendicitis is reported as a side effect among people who take Prandin (repaglinide), especially for people who are female, 50-59 old, also take Nexium, and have Osteoporosis.

The phase IV clinical study analyzes which people have Appendicitis when taking Prandin. It is created by eHealthMe based on reports of 4,613 people who have side effects when taking Prandin from the FDA, and is updated regularly.

What is Prandin?

Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,680 Prandin users. Check the latest studies of Prandin.

What is Appendicitis?

Appendicitis (inflammation of the appendix) is found to be associated with 835 drugs and 895 conditions by eHealthMe. Check the latest studies of Appendicitis.

On Jul, 16, 2026

4,613 people reported to have side effects when taking Prandin.
Among them, 29 people (0.63%) have Appendicitis.

Among these 29 people:

What is the gender of people who have Appendicitis when taking Prandin? *

female: 100 %
male: 0.0 %

What is the age of people who have Appendicitis when taking Prandin? *

What are other drugs people take besides Prandin? *

What are other side effects people have besides Appendicitis? *

Wound Infection Staphylococcal: 27 people, 93.10%
Malocclusion (a misalignment): 27 people, 93.10%
Gingival Pain (gum pain): 27 people, 93.10%
Gingivitis (inflammation of gums): 27 people, 93.10%
Gums - Swollen: 27 people, 93.10%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 27 people, 93.10%
Humerus Fracture (injury to the upper arm bone): 27 people, 93.10%
Joint Dislocation (a joint position is changed from normal position): 27 people, 93.10%
Lung Disorder (lung disease): 27 people, 93.10%
Metastatic Neoplasm (spreadable cancer tumour): 27 people, 93.10%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 27 people, 93.10%
Osteoporosis (bones weak and more likely to break): 27 people, 93.10%
Thrombocytopenia (decrease of platelets in blood): 11 people, 37.93%

* Approximation only. Some reports may have incomplete information.

Do you take Prandin and have Appendicitis?

- Check whether Appendicitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prandin:

Prandin (4,680 reports)

Appendicitis treatments and more:

Appendicitis (11,953 reports)

Browse all side effects of Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appendicitis:

Appendicitis (835 drugs)

Browse all the conditions that are associated with Appendicitis:

Appendicitis (895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on repaglinide (the active ingredients of Prandin) and Prandin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.